Laumas Sandeep 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 28, 2023
Insider Transaction Report
Form 4
Laumas Sandeep
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-26+17,000→ 17,000 totalExercise: $17.52Exp: 2033-06-26→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.